Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
TAF + Emtricitabine + Darunavir + Cobicistat bulk supplier for pharma manufacturers

TAF + Emtricitabine + Darunavir + Cobicistat Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: Darunavir- 800 mg + Cobicistat-1 50 mg + Emtricitabine- 200 mg + TAF-10 mg

Reference Brands: Symtuza(Eu & US)

Category: Anti Viral

Darunavir, cobicistat, emtricitabine and tenofovir alafenamide (800/150/200/10 mg) single-tablet HIV-1 regimen. For importers, distributors, HIV clinics and hospital pharmacies needing a once-daily boosted protease inhibitor combination.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export TAF + Emtricitabine + Darunavir + Cobicistat? List it or send an offer →

Product Description:

This tablet joins a boosted protease inhibitor and a nucleoside backbone as one complete daily regimen for HIV-1. Darunavir 800 mg blocks the viral protease, so new virus particles cannot mature. Cobicistat 150 mg, a CYP3A inhibitor without antiviral action, boosts darunavir enough for once-daily dosing. Emtricitabine 200 mg and tenofovir alafenamide 10 mg block reverse transcriptase. Boosted darunavir has a high genetic barrier to resistance. The pack data print cobicistat as 1 50 mg; the correct figure is 150 mg.

It is used in adults and adolescents from 12 years weighing at least 40 kg, to start treatment or to switch while virologically suppressed, where no darunavir resistance is known. It is taken once daily with food. Darunavir contains a sulphonamide group, so caution is needed in sulphonamide allergy, and severe skin reactions and hepatitis are labelled risks. As with other cobicistat products the interaction list is wide. Stopping can trigger a hepatitis B flare in co-infected patients. Cobicistat-boosted darunavir is not recommended in pregnancy because exposure falls.

Sourcing notes. The tablet is prescription-only and registered nationally, and many markets still hold patent or data protection on it, so check the legal position before a generic filing. Generic dossiers need bioequivalence data for all four actives. Supply comes in HDPE bottles with a desiccant; tablets stay in the original bottle, tightly closed, at room temperature. Ask for the batch CoA, GMP certificate and CoPP, with stability covering zone IVb. Give bottle count, label languages and the age and weight wording you need in the leaflet.

TAF + Emtricitabine + Darunavir + Cobicistat — third party manufacturing & bulk supply

TAF + Emtricitabine + Darunavir + Cobicistat is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

TAF + Emtricitabine + Darunavir + Cobicistat is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of TAF + Emtricitabine + Darunavir + Cobicistat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for TAF + Emtricitabine + Darunavir + Cobici... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

This combination is used for the treatment of HIV-1 infection. It works by suppressing viral replication, increasing CD4 cell counts, and helping achieve long-term viral suppression when used as part of antiretroviral therapy.

It is made from the active ingredients tenofovir alafenamide (TAF), emtricitabine, darunavir, and cobicistat. TAF and emtricitabine are nucleoside reverse transcriptase inhibitors, darunavir is a protease inhibitor, and cobicistat is a pharmacokinetic enhancer.

A known trade name for this four-drug fixed combination is Symtuza in the USA, EU, and UK.

Symtuza is manufactured by Janssen (Johnson & Johnson) in collaboration with Gilead Sciences.

The generic name is tenofovir alafenamide + emtricitabine + darunavir + cobicistat.

The main brand name is Symtuza.

It is manufactured by Janssen in the EU/USA, with production also handled through their authorized global manufacturing partners.

Related Products

Tenofovir AF + Emtricitabine + Bictegravir

Strength:
Bictegravir-50 mg + Emtricitabine-200 mg + TAF-25 mg

Form: Tablet

Reference Brands: Biktarvy(EU & US)

View Details
TAF + Emtricitabine + Rilpivirine

Strength:
(TAF) – 25 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg

Form: Tablet

Reference Brands: Odefsey(US & EU)

View Details
Glecaprevir + Pibrentasvir

Strength:
Glecaprevir- 100 mg + Pibrentasvir - 40 mg

Form: Tablet

Reference Brands: Mavyret (US); Maviret (EU)

View Details
TAF + Emtricitabine + Elvitegravir + Cobicistat

Strength:
Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TAF – 10 mg

Form: Tablet

Reference Brands: Genvoya(US & EU)

View Details
Fostemsavir

Strength:
600 mg

Form: Tablets

Reference Brands: Rukobia (USA)

View Details
Lenacapavir

Strength:
300 mg, 463.5 mg/1.5 mL

Form: Tablet / Injection

Reference Brands: Yeztugo (USA), Sunlenca (USA)

View Details
Brincidofovir

Strength:
100 mg, 10 mg/ml

Form: Tablets / Oral suspension

Reference Brands: Tembexa (USA/EU)

View Details
Cobicistat

Strength:
150 mg

Form: Tablets

Reference Brands: Tybost (USA/EU)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us